Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
August 18, 2017Aaron T. Gerds, MD, MS: Optimal use of lenalidomide as therapy for MDSWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201723 minPlay
August 18, 2017Amy E. DeZern, MD, MHS: New opportunities in experimental therapeutics in MDSWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201723 minPlay
August 18, 2017Carlos E. Bueso-Ramos, MD, PhD: MF marrow morphology: Key takeaways from WHO 2016 diagnostic updateWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201722 minPlay
August 18, 2017Craig M. Kessler, MD: What is new in thrombosis in MPNWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201731 minPlay
August 18, 2017Raajit K. Rampal, MD, PhD: Therapeutic insights in clonal evolution of MPN to accelerated or blastic phaseWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201722 minPlay
August 18, 2017Olatoyosi Odenike, MD: My approach to MF managementWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201721 minPlay
August 18, 2017Srdan Verstovsek, MD, PhD and Rami Komrokji, MD: Highlights in MPN and MDS - US PerspectiveKey Insights: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201724 minPlay
August 18, 2017David A. Sallman, MD: Myelodysplastic syndromes: Genomic landscapeWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201719 minPlay
August 18, 2017Christopher B. Benton, MD: Advances in understanding of MDS microenvironmentWebcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201717 minPlay
August 18, 2017Srdan Verstovsek, MD, PhD: Experimental therapeutics in MPN: Where is the field going?Webcast: US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201730 minPlay